PARADIGM-HF Trial

A new class of drug (Neprilysin inhibitor ) when combined with angiotensin receptor blocker , has been shown to be better than Enalapril.

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure — NEJM.

Leave a Reply